Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $3,084.8M | $3,327.6M | $3,590.8M | $4,068.2M | $4,505.2M | $4,694.7M | $5,003.9M | $5,542.3M | $5,671.4M | $5,808.3M | $6,011.6M | $8,680.1M | $9,641.8M | $10.4B | $11.3B | $11.6B | $14.0B | $16.1B | $14.9B | $12.2B |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Laboratory Corporation of America Holdings's last 12-month Revenue is $12.7B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Laboratory Corporation of America Holdings's Revenue growth was (6.1%). The average annual Revenue growth rates for Laboratory Corporation of America Holdings have been (6.0%) over the past three years, 2.2% over the past five years.
Over the last year, Laboratory Corporation of America Holdings's Revenue growth was (6.1%), which is lower than industry growth of 0.3%. It indicates that Laboratory Corporation of America Holdings's Revenue growth is Bad.